Mee S. Yoon

Hwasun, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Analysis of IMRT patient specific quality assurance using EPID measurement data from the Halcyon linear accelerator.

Analysis of IMRT patient specific quality assurance using EPID measurement data from the Halcyon linear accelerator.

Journal: PloS one

Published: December 15, 2025

Comparison of definitive radiotherapy outcomes between younger and older patients with high- or very-high-risk prostate cancer.

Comparison of definitive radiotherapy outcomes between younger and older patients with high- or very-high-risk prostate cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 26, 2024

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer.

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer.

Journal: Oncology letters

Published: January 31, 2023

Randomized, Multicenter, Phase 3 Study of Accelerated Fraction Radiation Therapy With Concomitant Boost to the Gross Tumor Volume Compared With Conventional Fractionation in Concurrent Chemoradiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: The Korean Radiation Oncology Group 09-03 Trial.

Randomized, Multicenter, Phase 3 Study of Accelerated Fraction Radiation Therapy With Concomitant Boost to the Gross Tumor Volume Compared With Conventional Fractionation in Concurrent Chemoradiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: The Korean Radiation Oncology Group 09-03 Trial.

Journal: International journal of radiation oncology, biology, physics

Published: June 26, 2022

Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model.

Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model.

Journal: BMC cancer

Published: March 13, 2022

PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy.

PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy.

Journal: Radiation oncology journal

Published: October 14, 2021

Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer.

Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer.

Journal: Cytotherapy

Published: August 10, 2021

Live cell imaging of highly activated natural killer cells against human hepatocellular carcinoma in vivo.

Live cell imaging of highly activated natural killer cells against human hepatocellular carcinoma in vivo.

Journal: Cytotherapy

Published: July 29, 2020

Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board.

Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board.

Journal: Translational lung cancer research

Published: July 18, 2020

Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.

Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.

Journal: PloS one

Published: April 02, 2020

Imaging Calreticulin for Early Detection of Immunogenic Cell Death During Anticancer Treatment.

Imaging Calreticulin for Early Detection of Immunogenic Cell Death During Anticancer Treatment.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 17, 2020

A dummy-run evaluation of postoperative hypofractionated intensity-modulated radiation therapy (POHIM-RT) trials for cervical cancer.

A dummy-run evaluation of postoperative hypofractionated intensity-modulated radiation therapy (POHIM-RT) trials for cervical cancer.

Journal: Journal of radiation research

Published: January 20, 2020

Showing 1-12 of 49

Last Updated: 09/26/2026